LifeMD provides direct-to-patient telehealth services with virtual medical consultations, subscriptions to its platform, and online sales of prescription medications and wellness products. It offers 24/7 virtual primary and urgent care, chronic disease management, and mental health services with same-day appointments and online prescriptions. The company stands out by combining a subscription model with an online pharmacy and dedicated verticals like RexMD for men’s health and a GLP-1 weight-management program, plus recent moves to expand private and public insurance coverage. Its goal is to make affordable, clinician-guided care available nationwide and grow its customer base and profitability through broader insurance coverage and scalable telehealth and drug distribution.
Company Size
201-500
Company Stage
IPO
Headquarters
Boynton Beach, Florida
Founded
2010
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Unlimited Paid Time Off
Paid Holidays
Short Term Disability
Training Programs
Professional Development Budget
Commuter Benefits
AT&T becomes the first and only carrier to offer free access to virtual healthcare powered by LifeMD. Sep 15, 2026, 09:00 ET DALLAS, Sept. 15, 2026 /PRNewswire/ - Through an exclusive collaboration with LifeMD, eligible AT&T wireless and fiber customers receive a complimentary LifeMD membership, a $228 annual value, with on-demand access to a nationwide virtual care and pharmacy platform. Key Takeaways: * More than 100 million eligible AT&T wireless and fiber customers will receive complimentary access to LifeMD's virtual care and pharmacy platform. * The $19-per-month LifeMD membership fee will be fully waived, a value of $228 per year.[1] * Members can connect with providers for everyday health needs and prescriptions, with many medications shipped directly from LifeMD's pharmacy. * The benefit is available through AT&T's &More program, which allows members to unlock savings and special offers. What's the News: AT&T is delivering more value to eligible wireless and fiber customers through an exclusive collaboration with LifeMD, a leading virtual care and pharmacy services provider. Eligible customers receive a complimentary LifeMD membership, connecting them to a nationwide virtual care and pharmacy platform that offers convenient access to healthcare from virtually anywhere. Why it Matters: More people are turning to virtual care to get the healthcare they need. A recent study revealed 82% of patients said telemedicine helps them stay on track with their health, while 78% said it makes healthcare easier to access. Through LifeMD, AT&T is helping remove barriers to care and medication access, giving customers a simpler way to manage their health. Quotable: "AT&T connects customers to the things that matter most, and healthcare is one of them. As virtual care becomes an increasingly important option, this offer gives eligible customers a simpler, more accessible way to manage their well-being," said Jenifer Robertson, executive vice president & GM, AT&T Consumer. "Together with LifeMD, we're using connectivity to expand access to care and help more people get support when and where they need it." "AT&T connects tens of millions of households across the country, and together we're making something new available to them: a complete virtual care and pharmacy experience," said Justin Schreiber, Chairman and CEO of LifeMD. "This is a landmark moment for LifeMD and, more importantly, for the millions of Americans who have been priced out of convenient, high-quality healthcare. Members can reach a state-licensed provider from their phone at their convenience and get care for a wide range of everyday health needs. We've built the healthcare platform today's consumer wants, and this collaboration puts it in front of one of the largest customer bases in America." More Details: Eligible customers must enroll to receive a complimentary LifeMD membership, helping put convenient care within reach without a monthly fee. Once enrolled, customers can choose the care that meets their needs and pay only for the visits, prescriptions, or services they use. 29 million AT&T customers in 11 states will be the first to receive this new benefit, with additional markets joining in January 2027 as it expands nationwide. Customers can learn more and enroll through the AT&T website or the AT&T mobile app. Frequently Asked Questions: Who is eligible[2] for the LifeMD benefit? All current AT&T wireless and fiber customers are eligible for complimentary access to LifeMD's virtual care and pharmacy platform. The benefit will initially be available in select states (AZ, FL, NC, IL, MD, NM, IA, TX, NY, CA, and MI), with expansion to additional states planned for January 2027. What does "complimentary access" include? AT&T customers receive LifeMD membership at no cost, with the $19 monthly membership fee fully waived. Members pay only for the care they need, with visits starting at $29 for message-based care, $49 for urgent and primary care video visits with state-licensed providers, and $79 for specialty care. For visits and prescriptions, customers can choose to use insurance, Medicare, or discounted cash-pay rates. AT&T customers will have access to LifeMD's nationwide virtual care and pharmacy platform, including: * Virtual primary care and 24/7 urgent care, with same-day prescriptions for common conditions like infections, allergies, and asthma * Ongoing medications for chronic conditions such as high blood pressure and high cholesterol * Weight management, including GLP-1 medications * Women's health, including perimenopause and menopause care and hormone replacement therapy * Men's health, including testosterone and sexual health treatment * Prescription dermatology, hormone health, sleep, and laboratory services * Same-day prescriptions and refills, when clinically appropriate, with many medications shipped directly from LifeMD's pharmacy and others sent to the member's local pharmacy How do customers sign up for the benefit? Customers can learn more about the benefit and enroll through the AT&T website, mobile app, and other digital channels. Once enrolled, they can use the LifeMD platform to connect with state-licensed providers, fill and manage prescriptions through LifeMD's pharmacy, and access a range of virtual care services. [1] Limited time offer. Only monthly fee waived; costs of care, visits, and prescriptions not included. Not available in all states. Customers must be 18 or older. Additional restrictions and requirements may apply. See here for more details, terms, and conditions. [2] Not all offerings are available in all states. Customers must be 18 or older. Some offerings may have additional eligibility restrictions. About AT&T We help more than 100 million U.S. families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility. From the first phone call 150 years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives. For more information about AT&T Inc. (NYSE: T), please visit us at about.att.com. Investors can learn more at investors.att.com. About LifeMD LifeMD(R)(Nasdaq: LFMD) is a leading virtual care company making high-quality healthcare more accessible, convenient, and affordable. Through its vertically integrated platform, LifeMD connects patients with a 50-state affiliated medical group, laboratory services, a state-of-the-art nationwide pharmacy with home delivery, and a U.S.-based patient care center. Together, these capabilities support care across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. For more information, please visit LifeMD.com. SOURCE AT&T
LifeMD reported second-quarter 2026 revenue of $47.3 million, within its guidance range. The telehealth company posted an adjusted EBITDA loss of approximately $3.5 million. The loss reflected elevated customer acquisition costs earlier in the quarter and a new $39 introductory offer. Chief executive Justin Schreiber acknowledged the company missed its own targets, attributing the shortfall to a restructuring of its customer acquisition model during the quarter. Schreiber noted that whilst elevated media costs were temporary and adjusted EBITDA improved throughout the quarter, the company needed to address the performance directly. The results were released on 5 August 2026, following the market close.
LifeMD (NASDAQ: LFMD) Stock Analysis: KeyBanc Maintains Overweight Rating Amid Q2 earnings. Aug 07, 2026 Market News FMPLifeMD (NASDAQ: LFMD) Stock Analysis: KeyBanc Maintains Overweight Rating Amid Q... * KeyBanc maintained an Overweight rating for LifeMD (NASDAQ: LFMD), a leading telehealth stock, despite its second-quarter revenue falling short of consensus estimates. * Despite the revenue miss, the company demonstrated strong underlying profitability with a significant gross margin expansion and robust subscriber growth. * LifeMD is strategically transitioning its weight management program towards branded GLP-1 therapies, signaling a strong future growth driver and operational shift. On August 7, 2026, analyst firm KeyBanc maintained its Overweight rating for LifeMD (NASDAQ: LFMD). LifeMD is a prominent telehealth company providing virtual medical care, specializing in weight management solutions and women's health. At the time of the rating, the stock was trading at a price of $3.40 per share. The rating follows the company's second-quarter 2026 results. LifeMD reported revenue of $47.30 million, which was within its guidance. However, as highlighted by Zacks, this figure missed consensus estimates by 3.7% and was a decline from the $62.22 million reported in the same quarter of the previous year, impacting the overall financial performance. Despite the revenue miss, the company's underlying profitability metrics show some positive signs. Gross margin, which is revenue minus the cost of goods sold, expanded to approximately 89%. This improvement is mainly due to lower shipping costs and the scaling of its own in-house pharmacy operations, enhancing the company's operational efficiency. The company did report an adjusted EBITDA loss of approximately $3.50 million. Adjusted EBITDA is a key measure of a company's operating performance. This loss was attributed to higher customer acquisition costs and a new, lower $39.00 introductory price for its branded GLP-1 weight management program, a strategic move to boost subscriber growth. However, key growth drivers appear strong for the telehealth provider. Total active subscribers grew 20% year-over-year to approximately 356,000. Furthermore, about 95% of new weight management patients are starting with branded GLP-1 therapies, signaling the company is near the end of its transition away from compounded medications and focusing on high-value services. Market news and analyst rating coverage Gordon Thompson covers analyst rating changes, price-target updates, and company news for the FMP blog. His work focuses on summarizing the latest broker actions and market developments into accessible, data-driven updates for investors and analysts. Financial data for every need. Real-time quotes and 30+ years of historical data, including prices, fundamentals, and insider transactions - all accessible via API. Stock Screener 2017-2026 (C) FMP
LifeMD has announced an exclusive telehealth co-marketing collaboration with Antares Pharma for XYOSTED, the only FDA-approved once-weekly subcutaneous testosterone auto-injector. The direct-to-patient self-pay programme will launch in July 2026 across 37 US states. Under the agreement, LifeMD will serve as exclusive telehealth partner for the XYOSTED self-pay programme. Patients will be evaluated by licensed clinicians through LifeMD's affiliated medical group, with LifeMD's pharmacy dispensing and shipping XYOSTED directly to homes at approximately $249 per month, covering both medication and care without insurance. The companies will jointly invest in consumer education and promotional initiatives to raise awareness of testosterone deficiency. XYOSTED is self-administered weekly, with 99.4% of injections reported pain-free in pivotal clinical studies.
LifeMD, a direct-to-patient telehealth company, has appointed Umesh Sripad as chief technology officer, effective immediately. Sripad will lead technology strategy, platform transformation, AI enablement and cybersecurity as the company expands its services. Sripad brings over 20 years of experience in digital modernisation and transformation. He joins from PetMeds, where he served as chief digital and technology officer. He has previously held senior roles at Bed Bath & Beyond, IKEA USA, Overstock.com and CNN. LifeMD has grown from a men's virtual pharmacy into a 50-state platform serving nearly 350,000 patients across primary care, specialty care and pharmacy services. As part of his employment package, Sripad will receive 150,000 restricted stock units, with vesting tied to service milestones and performance targets.